CDIO - Cardio Diagnostics H...

Financial Statements of Cardio Diagnostics Holdings, Inc.(CDIO), Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for c

Cardio Diagnostics Holdings, Inc.

CDIO

NASDAQ

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

0.468 USD

0.0022 (0.47%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

FMP

Home Terms of Service Privacy Policy Blog Careers FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.